New evidence demonstrates link between smoking, prostate cancer prognosis
the ONA take:
The association between smoking and the development of various forms of cancer are well established; however, evidence of such a link with prostate cancer is contradictory.
Now, an international study led by MedUni Vienna and Basle University Hospital has found evidence of a clear link.
The study combined data on 7,191 patients with prostate cancer who underwent radical prostatectomy, with no preoperative treatments.
The results showed that risk of biochemical recurrence of prostate for smokers and ex-smokers was twice that of nonsmokers. However, this negative effect can be offset within 10 years of quitting.
Although this research still does not clarify, in scientific terms, whether smoking is associated with the development of prostate cancer, it does demonstrate that smoking increases the risk of dying from the disease.
The researchers acknowledge that further research is needed, but stress the significance of quitting smoking even for those who are already suffering from prostate cancer.
Association between smoking and development of various forms of cancer well established; however, evidence of prostate cancer link contradictory.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|